Organization · Venture Capital
Keio Innovation Initiative, Inc.
Keio Innovation Initiative, Inc. is a university-affiliated venture capital firm based in Tokyo, Japan, focusing on seed and early-stage investments in startups that commercialize academic research, particularly in healthcare and digital technology.
Overview
What Keio Innovation Initiative, Inc. does
What Keio Innovation Initiative, Inc. is
Keio Innovation Initiative, Inc. is a university-affiliated venture capital firm based in Tokyo, Japan, focusing on seed and early-stage investments in startups that commercialize academic research, particularly in healthcare and digital technology.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Keio Innovation Initiative, Inc. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Keio Innovation Initiative, Inc. as a funder
Investment thesis
KII invests in startups commercializing research from Keio University and other Japanese academic institutions, focusing on societal advancement through academic research commercialization.
Focus narrative
KII invests in seed and early-stage startups, particularly those addressing social issues in the fields of healthcare and digital technology. The organization aims to provide lead investments and actively participates in follow-on funding. KII collaborates with external experts and utilizes public support systems to offer hands-on assistance to its portfolio companies.
Value beyond capital
KII provides hands-on assistance to its portfolio companies by leveraging its connections with academia and industry experts. The organization actively participates in follow-on funding and utilizes public support systems to enhance the growth and commercialization of its investments.
Terms and economics
- Typical check
- $270,000–$6,700,000
Focus and fit
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 51
- Recorded notable exits
- QON, Inc., Institution for a Global Society, Inc., Synspective, Inc., Axelspace Holdings, Inc., Kringle Pharma, Inc., and Tsubota Lab, Inc., plus 1 more
Portfolio context
KII's portfolio includes notable companies such as Synspective, which specializes in SAR satellite data analytics, CureApp, a leader in digital therapeutics, and Heartseed, focused on cardiac regenerative medicine. Other significant investments include B dot Medical, which develops cancer therapy equipment, and Cellusion, which works on regenerative medicine for corneal treatment.
Common questions
What to know about Keio Innovation Initiative, Inc.
Upseed classifies Keio Innovation Initiative, Inc. under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.